GlassScriptPhysician profile
Jennifer G Kaiser Blase
NPI 1649486101
$2,104.80
in general payments reported to CMS, 2019-2025
30 companies · $434 in 2025
The $434 reported for 2025 was more than what 77% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $207 · 2020: $92.56 · 2021: $139 · 2022: $435 · 2023: $403 · 2024: $395 · 2025: $434.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,132 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,132.49 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $255.99 | 2023-2025 | Myfembree |
| Astellas Pharma US INC | $249.18 | 2024-2025 | Veozah |
| Abbvie INC. | $241.44 | 2019-2023 | |
| Myovant Sciences INC. | $170.55 | 2022 | |
| Sage Therapeutics, LLC | $144.48 | 2023-2024 | |
| Hologic Sales and Service, LLC | $139.51 | 2019-2025 | Coolseal Generator, Novasure, Acessa Provu System |
| Exeltis, USA INC. | $124.87 | 2019-2025 | Slynd |
| Organon LLC | $106.46 | 2022-2025 | Nexplanon |
| Mayne Pharma Commercial LLC | $81.40 | 2021-2024 | |
| Minerva Surgical, INC | $63.06 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $52.42 | 2019-2023 | |
| Lupin INC. | $50.29 | 2019-2020 | |
| Coopersurgical, INC. | $43.80 | 2019-2022 | |
| Ethicon US, LLC | $42.55 | 2019-2024 | Vistaseal, Enseal |
| Medtronic, INC. | $33.72 | 2025 | Truclear |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $32.47 | 2024-2025 | Femlyv, Intrarosa |
| Ferring Pharmaceuticals INC. | $30.39 | 2019 | |
| Dexcom, INC. | $26.52 | 2025 | Dexcom G6 Transmitter |
| Gynesonics, INC. | $26.09 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Daiichi Sankyo INC. | $24.08 | 2025 | Injectafer |
| Myriad Women'S Health, INC. | $22.71 | 2023 | Myrisk |
| Pfizer INC. | $20.18 | 2023 | |
| Channel Medsystems, INC. | $18.18 | 2025 | |
| Mylan Pharmaceuticals INC. | $16.89 | 2022 | |
| Therapeuticsmd, INC. | $16.69 | 2022 | |
| Shield Therapeutics INC | $15.90 | 2025 | |
| Merck Sharp & Dohme LLC | $15.81 | 2021 | |
| Evofem Biosciences, INC. | $14.65 | 2021 | |
| Dysis Medical, INC. | $13.28 | 2020 | |
| Allergan, INC. | $11.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Kaiser Blase listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.